• Epithelial mesenchymal transition EMT is the process by whic

  2024-12-25

  

  Epithelial-mesenchymal transition (EMT) is the process by which epithelial cells are trans-differentiated into motile mesenchymal cells. During EMT, epithelial cells reorganize their cortical Rp-8-Br-PET-cGMPS australia cytoskeleton, lose their junctions and apical-basal polarity, change cell shape

• We have previously reported alterations of the thymus in ACh

  2024-12-25

  

  We have previously reported alterations of the thymus in AChR-MG patients, especially in their germinal center ap-1 transcription factor (defined as CD19+CD38+ cells by flow cytometric analysis). First, we found that, in MG thymi, this subset failed to show the normal down-regulation of Bcl-2, sugg

• br Conclusion Biotransformation of trachyloban oic acid by S

  2024-12-25

  

  Conclusion Biotransformation of trachyloban-19-oic PSB 0777 ammonium salt australia by S. racemosum provided three products. Oxidation of compound 1 at C-17 (2–3), as well as rearrangement of 1 into a kaurane diterpene hydroxylated in C-16 and C-17 (4) were crucial for increasing AChE inhibitory

• Although the mechanisms of APP secretion are well

  2024-12-25

  

  Although the mechanisms of APP secretion are well characterised (for review see Ref. [1]), production of soluble AChE species is less well understood although we have reported that a metalloproteinase can shed AChE similarly to APP [16], [17]. Recently it has also been demonstrated that cellular pre

• The role of DHT in early teleost embryogenesis

  2024-12-25

  

  The role of DHT in early teleost embryogenesis is not entirely clear or established, however additional studies that treat fish embryos to DHT or to specific srd5a inhibitors at critical stages of development (i.e. prior to sex differentiation) will shed light on the early functions of this androgen

• br Materials and methods br Results br Discussion

  2024-12-25

  

  Materials and methods Results Discussion We have developed a high-throughput functional genomic screen that allows the identification of genes that confer drug resistance. Several factors have been identified which must be taken into account to develop a reliable screen. In particular, cons

• The first description of autophagy as a tumour suppression p

  2024-12-25

  

  The first description of autophagy as a tumour suppression process arises from the observation that the initial step regulatory gene, Atg6/BECN1, was monoallelically lost in 40% to 75% of human prostate, breast, and ovarian cancers [31]. However, while BECN1 heterozygous mutant mice develop, with lo

• However most of these SBVS

  2024-12-24

  

  However, most of these SBVS studies were focused on the target(s) for which crystal structures were available or have a similar template in PDB for comparative modeling. Besides, these were limited to SBVS only which relies on the rigid binding pocket, therefore, it may result in high false positive

• The elevated levels of intracellular antioxidant such as

  2024-12-24

  

  The elevated levels of intracellular antioxidant such as reduced glutathione (GSH) are normally oberserved is various tumor BS-181 which confers the chemoresistant to chemotherapy [59]. Therefore, the induction of oxidative stress via elevation of intracellular ROS and dimunition of intracellular G

• Most clinically approved antiangiogenic drugs are aimed

  2024-12-24

  

  Most clinically approved antiangiogenic drugs are aimed at blocking the action of vascular endothelial growth factor, or VEGF, which is accepted to be the most important tumor-derived angiogenic factor, stimulating proliferation and migration of endothelial cells, as well as branching of vessels (Fe

• In the present study a splice acceptor site mutation c

  2024-12-24

  

  In the present study, a splice acceptor site mutation (c.1769-1G > C) was identified in AR gene from patients with CAIS. The c.1769-1G > C mutation results in replacement of the normal sequence (CAG/G) with a new sequence (CAC/G) at the splice acceptor site of intron 2. In the splice acceptor site r

• Initially DPP DPP and prolyl tripeptidyl peptidase A

  2024-12-24

  

  Initially, DPP4, DPP7, and prolyl tripeptidyl peptidase A (PtpA) were the only exopeptidases identified in P. gingivalis. These share substrates according to their altered specificities, as DPP4 is highly specific for Pro at the penultimate position from the N-terminus (P1 position), though it accep

• br Aldehyde sensors to monitor

  2024-12-24

  

  Aldehyde sensors to monitor substrate levels Previous efforts to ameliorate metabolic diseases frequently relied on biochemical methods which could measure the levels of toxic substrates in Anticancer therapy or bodily fluids (blood and serum or plasma, urine, cerebrospinal fluid). Therapeutic e

• br Does TIPARP contribute to the diverse species sensitivity

  2024-12-24

  

  Does TIPARP contribute to the diverse species sensitivity to TCDD toxicity? In chick embryo hepatocytes TIPARP was reported to mediate the TCDD-dependent suppression of hepatic gluconeogenesis, by reducing cellular NAD+ levels and reducing PCK1 expression, suggesting that ADP-ribosylation enhance

• Human testicular peritubular cells HTPCs

  2024-12-24

  

  Human testicular peritubular KPT-9274 (HTPCs) are also the only human testicular cell type that can be isolated, cultured and studied in vitro (Albrecht et al., 2006, Mayerhofer, 2013). Results from recent studies indicate that their roles go beyond sperm transport and include immunological functio

15012 records 2/1001 page Previous Next 12345 下5页 Last page